Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.47 |
| ▸ | FABP7 | O15540 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31220527 | 1.00 | TSHR (0.52) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL30276687 | 1.00 | TSHR (0.52) | TSHRKMT2AFABP5FABP7POLB | |
| Hydrochloric Acid SCHEMBL28773949 | 0.98 | TSHR (0.51) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL30824716 | 0.98 | TSHR (0.50) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL30555288 | 0.98 | TSHR (0.50) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL8222797 | 0.98 | TSHR (0.50) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL22397770 | 0.92 | POLB (0.52) | TSHRKMT2AFABP5FABP7POLB | |
| SCHEMBL13327274 | 0.92 | POLB (0.52) | TSHRKMT2AFABP5FABP7POLB | |
| Trifluoroacetic Acid SCHEMBL28773939 | 0.91 | TSHR (0.45) | TSHRKMT2AFABP5FABP7POLB | |
| Formic Acid SCHEMBL27577578 | 0.90 | KMT2A (0.45) | TSHRKMT2AFABP5FABP7POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116298027-A | Liquid chromatography detection method and application of genotoxic impurities | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20260124312-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LIMITED (GB) | 2026-05-07 | — | — | US | disclosed |
| US-20250262314-A1 | MULTIFUNCTIONAL ANTIBODIES | SYNAFFIX B.V. (NL) | 2025-08-21 | — | — | US | disclosed |
| EP-4592275-A2 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4582436-A2 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BicycleTX Limited (GB) | 2025-07-09 | — | — | EP | disclosed |
| EP-3727461-B1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LTD (GB) | 2025-07-09 | — | — | EP | disclosed |
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2025-06-26 | — | — | US | disclosed |
| EP-4362988-B1 | ANTIMICROBIAL PEPTIDES AND THEIR USE | UNIV MANCHESTER (GB) | 2025-06-25 | — | — | EP | disclosed |
| US-20250177537-A1 | AN ANTIBIOTIC, METHOD OF PREPARATION AND METHOD OF TREATMENT THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-06-05 | — | — | US | disclosed |
| EP-3074010-B1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE INC (US) | 2025-05-14 | — | — | EP | disclosed |
| US-5708153-A | PREPARING A LIBRARY | AFFYMAX TECHNOLOGIES N.V. (GB) | 1998-01-13 | — | — | US | disclosed |
| US-5670616-A | CAPABLE OF BEING STAINED WITH CATIONIC CARBOCYANINE DYE | EASTMAN KODAK COMPANY (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0773227-A1 | Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides | AFFYMAX TECHNOLOGIES N.V. (AN) | 1997-05-14 | — | — | EP | disclosed |
| EP-0604552-B1 | METHOD OF SYNTHESIZING DIVERSE COLLECTIONS OF OLIGOMERS | AFFYMAX TECH NV (AN) | 1997-02-12 | — | — | EP | disclosed |
| US-5580712-A | CONTROLLING THE GRAIN MORPHOLOGY BY A CULTURE PRODUCT POLYPEPTIDES | EASTMAN KODAK COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0604552-A1 | METHOD OF SYNTHESIZING DIVERSE COLLECTIONS OF OLIGOMERS. | AFFYMAX TECH NV (AN) | 1994-07-06 | — | — | EP | disclosed |
| EP-0604552-A4 | METHOD OF SYNTHESIZING DIVERSE COLLECTIONS OF OLIGOMERS. | AFFYMAX TECH NV (AN) | 1993-08-02 | — | — | EP | disclosed |
| EP-0537981-A2 | Cleavage method for acyl thiohydantoins and use of the method in C-terminal peptide sequencing | THE PERKIN-ELMER CORPORATION (US) | 1993-04-21 | — | — | EP | disclosed |
| WO-1993006121-A1 | METHOD OF SYNTHESIZING DIVERSE COLLECTIONS OF OLIGOMERS | AFFYMAX TECHNOLOGIES N.V. (NL) | 1993-04-01 | — | — | WO | disclosed |
| US-5185266-A | Cleaving an alkylated thiohydantoin adduct from a peptide under anhydrous, acidic conditions and analyzing the side chain of the amino acid | APPLIED BIOSYSTEMS, INC. (US) | 1993-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | CDK1, CDK11A, CDK3 | TSHR 3696/4885KMT2A 1352/4885FABP5 4471/4885 |
| US-20260124312-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | EPHA2, EPHB2, ERBB2 | TSHR 801/4885KMT2A 1304/4885FABP5 2727/4885 |
| US-20250177537-A1 | AN ANTIBIOTIC, METHOD OF PREPARATION AND METHOD OF TREATMENT THEREOF | BTD, CALCR, CA6 | TSHR 3789/4885KMT2A 1230/4885FABP5 1053/4885 |
| US-20250262314-A1 | MULTIFUNCTIONAL ANTIBODIES | C1S, APOL1, BTN3A1 | TSHR 2191/4885KMT2A 3361/4885FABP5 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.